ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 醫學院 > 癌症生物學研究所 > 期刊論文 > Item 310903500/31231

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/31231

题名:	ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway
作者:	(Kuo, H-P);(Lee, D-F);(Chen, C-T.);(Liu, M.);(Chou, C-K.);(Lee, H. J.);(Xie, X.);(Wei, Y.);(Xia, W);(Zhang, W.);(Yi, D.);(Yang, J-Y.);(Huang, T-H);(Yen, C-J.);(Tan, M);(Xing, G);(Zhao, Y);(Lin, C-H);(Tsai, S-F);(Fidler, I. J.);洪明奇(Mien-Chie Hung)*
贡献者:	醫學院癌症生物學研究所;中國附醫院長室
日期:	2010
上传时间:	2010-09-27 15:48:29 (UTC+8)
摘要:	Mammalian target of rapamycin (mTOR) regulates various cellular functions, including tumorigenesis, and is inhibited by the tuberous sclerosis 1 (TSC1)–TSC2 complex. Here, we demonstrate that arrest-defective protein 1 (ARD1) physically interacts with, acetylates, and stabilizes TSC2, thereby repressing mTOR activity. The inhibition of mTOR by ARD1 inhibits cell proliferation and increases autophagy, thereby inhibiting tumorigenicity. Correlation between ARD1 and TSC2 abundance was apparent in multiple tumor types. Moreover, evaluation of loss of heterozygosity at Xq28 revealed allelic loss in 31% of tested breast cancer cell lines and tumor samples. Together, our findings suggest that ARD1 functions as an inhibitor of the mTOR pathway and that dysregulation of the ARD1-TSC2-mTOR axis may contribute to cancer development.
關聯:	Science Signaling 3(108):ra9-ra9
显示于类别:	[癌症生物學研究所] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	513	检视/开启

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章